Corteva (NYSE:CTVA)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $29.98, but opened at $29.22. Corteva shares last traded at $28.30, with a volume of 8,487,707 shares traded.

A number of research firms have commented on CTVA. Vertical Research began coverage on Corteva in a research note on Thursday, December 19th. They set a “hold” rating and a $27.00 price target on the stock. UBS Group decreased their price target on Corteva from $33.00 to $32.00 and set a “buy” rating on the stock in a research note on Thursday, December 19th. SunTrust Banks decreased their price target on Corteva from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Barclays set a $32.00 price target on Corteva and gave the stock a “hold” rating in a research note on Friday, November 1st. Finally, Citigroup decreased their price target on Corteva from $34.50 to $31.00 and set a “buy” rating on the stock in a research note on Wednesday, October 9th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $30.73.

The business has a 50-day moving average price of $27.59 and a two-hundred day moving average price of $27.82.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, October 31st. The company reported ($0.39) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.46) by $0.07. The company had revenue of $1.91 billion for the quarter, compared to analysts’ expectations of $1.97 billion. The firm’s quarterly revenue was down 1.8% compared to the same quarter last year. Analysts predict that Corteva will post 1.23 earnings per share for the current fiscal year.

In other Corteva news, EVP Timothy P. Glenn bought 5,150 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The shares were purchased at an average price of $26.13 per share, with a total value of $134,569.50. Also, CEO James C. Jr. Collins bought 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The stock was acquired at an average cost of $25.50 per share, for a total transaction of $127,500.00. The disclosure for this purchase can be found here. Insiders have bought 15,975 shares of company stock worth $414,277 in the last ninety days.

A number of large investors have recently bought and sold shares of CTVA. Vanguard Group Inc. purchased a new position in Corteva in the second quarter valued at $1,803,496,000. BlackRock Inc. purchased a new position in shares of Corteva during the second quarter worth about $1,728,215,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Corteva during the second quarter worth about $579,764,000. Nuveen Asset Management LLC purchased a new position in shares of Corteva during the second quarter worth about $429,256,000. Finally, Price T Rowe Associates Inc. MD purchased a new position in shares of Corteva during the second quarter worth about $404,071,000. 74.91% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Company Profile (NYSE:CTVA)

Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.

Further Reading: What is a back-end load?

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.